These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2873208)

  • 1. Labetalol as monotherapy in hypertensive black patients.
    Cubberley RB
    J Clin Hypertens; 1985 Dec; 1(4):304-14. PubMed ID: 2873208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy with labetalol compared with propranolol. Differential effects by race.
    Flamenbaum W; Weber MA; McMahon FG; Materson BJ; Carr AA; Poland M
    J Clin Hypertens; 1985 Mar; 1(1):56-69. PubMed ID: 3915317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol in the treatment of hypertension in elderly and younger patients.
    Abernethy DR; Bartos P; Plachetka JR
    J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol compared with propranolol in the treatment of black hypertensive patients.
    Saunders E; Curry C; Hinds J; Kong BW; Medakovic M; Poland M; Roper K
    J Clin Hypertens; 1987 Sep; 3(3):294-302. PubMed ID: 3312502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP; Durier P; Bussiere JL; Gayet JL
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of labetalol in elderly patients with essential hypertension.
    Giles TD; Weber M; Bartels DW; Gregory MC; Burris JF; Due D; Sirgo MA
    J Clin Pharmacol; 1991 Jun; 31(6):556-60. PubMed ID: 1880221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA
    J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
    Townsend RR; DiPette DJ; Goodman R; Blumfield D; Cronin R; Gradman A; Katz LA; McCarthy EP; Sopko G
    Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
    Ohman KP; Weiner L; von Schenck H; Karlberg BE
    Eur J Clin Pharmacol; 1985; 29(2):149-54. PubMed ID: 3908121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
    Weidler DJ; Vidt DG; Toth PD; Due DL; Sirgo MA
    J Clin Pharmacol; 1990 Jun; 30(6):524-32. PubMed ID: 2355103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of labetalol in general medicine in aged patients with hypertension. Compliance, efficacy and safety in long-term treatment].
    Hugonot R; Hugonot L; Herrero G
    Ann Cardiol Angeiol (Paris); 1990 Nov; 39(9):547-53. PubMed ID: 2291621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of isolated systolic hypertension with labetalol in the elderly.
    Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
    Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
    Kochar MS; Tyson J; Kalbfleisch JH
    J Clin Pharmacol; 1985 Sep; 25(6):433-6. PubMed ID: 3902912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.